Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Abstract 1494: IgE receptor-activated human mast cells have potent anti-cancer properties

View through CrossRef
Abstract The purpose of this study was to test the hypothesis that human mast cells (MC) have anti-tumor mediators that can be targeted to tumor specific antigens, induced to release these mediators, and cause cancer cell apoptosis. Breast cancer (BC) continues to be a significant cause of mortality for women in the United States. The oncogene HER2/neu is overexpressed in BC and is validated target for cancer therapeutics. New immunotherapy strategies and combinations of immune agents with non-redundant mechanisms of action are needed. The role of human tissue mast cells (MC) in the pathology of many cancers is not known. Nonetheless, high densities of MC are associated with favorable prognosis in certain types of cancer such as BC suggesting an anti-tumor effect. We previously reported that human adipose cells can be differentiated into autologous, fully functional MC (ADMC) capable of releasing mediators upon FcϵRI stimulation that induce BC cell death of cell suspensions of SK-BR3. Further data is presented demonstrating the anti-tumor effects of ADMC using BC tumor masses. The ADMC, sensitized with breast cancer-specific IgE anti-HER2/neu, bound to and were activated by, HER2/neu-positive human BC cells. The anti-HER2/neu IgE-sensitized ADMC bound to, infiltrated, and induced apoptosis of HER2/neu-positive BT-474 BC tumor masses as determined by time-lapse, live cell confocal imaging. Specific, HER2/neu IgE-mediated binding was also verified in vivo using immunocompromised xenograft models. Further studies are warranted to determine if tumor-targeted, autologous MC may be a new way to treat solid tumors. Citation Format: Chris Kepley, Mohammad Ferrydouni, Mona Motaghed, Kristen Dellinger. IgE receptor-activated human mast cells have potent anti-cancer properties [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2021; 2021 Apr 10-15 and May 17-21. Philadelphia (PA): AACR; Cancer Res 2021;81(13_Suppl):Abstract nr 1494.
Title: Abstract 1494: IgE receptor-activated human mast cells have potent anti-cancer properties
Description:
Abstract The purpose of this study was to test the hypothesis that human mast cells (MC) have anti-tumor mediators that can be targeted to tumor specific antigens, induced to release these mediators, and cause cancer cell apoptosis.
Breast cancer (BC) continues to be a significant cause of mortality for women in the United States.
The oncogene HER2/neu is overexpressed in BC and is validated target for cancer therapeutics.
New immunotherapy strategies and combinations of immune agents with non-redundant mechanisms of action are needed.
The role of human tissue mast cells (MC) in the pathology of many cancers is not known.
Nonetheless, high densities of MC are associated with favorable prognosis in certain types of cancer such as BC suggesting an anti-tumor effect.
We previously reported that human adipose cells can be differentiated into autologous, fully functional MC (ADMC) capable of releasing mediators upon FcϵRI stimulation that induce BC cell death of cell suspensions of SK-BR3.
Further data is presented demonstrating the anti-tumor effects of ADMC using BC tumor masses.
The ADMC, sensitized with breast cancer-specific IgE anti-HER2/neu, bound to and were activated by, HER2/neu-positive human BC cells.
The anti-HER2/neu IgE-sensitized ADMC bound to, infiltrated, and induced apoptosis of HER2/neu-positive BT-474 BC tumor masses as determined by time-lapse, live cell confocal imaging.
Specific, HER2/neu IgE-mediated binding was also verified in vivo using immunocompromised xenograft models.
Further studies are warranted to determine if tumor-targeted, autologous MC may be a new way to treat solid tumors.
Citation Format: Chris Kepley, Mohammad Ferrydouni, Mona Motaghed, Kristen Dellinger.
IgE receptor-activated human mast cells have potent anti-cancer properties [abstract].
In: Proceedings of the American Association for Cancer Research Annual Meeting 2021; 2021 Apr 10-15 and May 17-21.
Philadelphia (PA): AACR; Cancer Res 2021;81(13_Suppl):Abstract nr 1494.

Related Results

Abstract B089: Intratumoral expression analysis of mast cells in high grade serous ovarian cancer
Abstract B089: Intratumoral expression analysis of mast cells in high grade serous ovarian cancer
Abstract Objective: The goal of this study is to examine intratumoral expression and phenotypic changes in mast cells following neoadjuvant chemotherapy (NACT) expos...
Divergent effects of acute and prolonged interleukin 33 exposure on mast cell IgE-mediated functions
Divergent effects of acute and prolonged interleukin 33 exposure on mast cell IgE-mediated functions
AbstractBackgroundEpithelial cytokines, including IL-33 and TSLP, have attracted interest because of their roles in chronic allergic inflammation-related conditions such as asthma....
Human skin–derived mast cells can proliferate while retaining their characteristic functional and protease phenotypes
Human skin–derived mast cells can proliferate while retaining their characteristic functional and protease phenotypes
AbstractHuman mast cells in adult tissues have been thought to have limited, if any, proliferative potential. The current study examined mast cells obtained from adult skin and cul...
Mast cells in the kidney
Mast cells in the kidney
SUMMARY: Mast cells have become a recent concern in the nephrological world. The development of antibodies to mast cell‐specific enzymes, tryptase and chymase, has facilitated the ...
Inhibition of IgE‐induced activation of human mast cells by IL‐10
Inhibition of IgE‐induced activation of human mast cells by IL‐10
Background IL‐10 exhibits anti‐inflammatory effects on activated rodent mast cells (MC) in vitro and inhibits allergen‐induced airway inflammation in vivo in murine models. The eff...
Human Tumor Targeted Cytotoxic Mast Cells for Cancer Immunotherapy
Human Tumor Targeted Cytotoxic Mast Cells for Cancer Immunotherapy
The diversity of autologous cells being used and investigated for cancer therapy continues to increase. Mast cells (MCs) are tissue cells that contain a unique set of anti-cancer m...
Inhibition of Immunoglobulin E Attenuates Pulmonary Hypertension
Inhibition of Immunoglobulin E Attenuates Pulmonary Hypertension
Abstract Pulmonary hypertension (PH) is a severe cardiopulmonary disease characterized by pathological vascular remodeling in the lung. Immunoglobulin E (IgE) is known to p...

Back to Top